Global R&D Funding Forecast
Featured Topics in Publications: R&D Magazine | Best R&D Companies | R&D Daily | Global R&D Funding Forecast | Lab Design Newsletter | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
12/22/2009 | Featured Articles
The global recession is over for most of the world, but the recovery reveals relatively meager R&D increases for most advanced economies—and strong gains for emerging economies.
12/22/2009 | Featured Articles
Sustained R&D investment is key to economic growth. Those are strong words that are easy to follow in good economic times, but more difficult to follow in bad economic times. The global recession that officially began in the U.S. in late-2007, and is expected to ‘officially’ end (for the U.S.) in late-2009, has been described as the worst economic recession since the Great Depression.
12/22/2009 | Featured Articles
The Battelle/R&D Magazine team forecasts the U.S. R&D environment will begin to re-emerge in 2010, with total R&D spending reaching $401.9 billion, up 3.27% over the final 2009 estimate of $389.2 billion.
12/22/2009 | Featured Articles
Whether you’re talking about a company or a country, the future holds critical challenges that will require innovative science and technology solutions.
12/22/2009 | Featured Articles
In the summer of 1945, Vannevar Bush, Director of the Office of Scientific Research and Development, delivered a report to President Roosevelt that laid the foundation to establish the National Science Foundation. It also articulated the rationale for basic research as a critical basis for national security in the broadest sense, not only for defense, but also for a robust economy.
12/22/2009 | Featured Articles
Though the readership of this publication may be somewhat biased, the public at large would likely agree that advanced technologies play a significant role in corporate and U.S. competiveness now and in the future. Yet, the relationships among R&D investment recipients, the importance of technology, and view of corporate and U.S. competiveness are murky at best.
12/22/2009 | Featured Articles
With final appropriations bills still undecided, R&D funding, combined with the Administration’s budget in the remaining departments and agencies, totals currently at $147.9 billion, which is an increase of 0.56%. Unless there are some significant Congressional additions, we are headed toward a baseline FY2010 federal budget that fails to keep up with inflation.
12/22/2009 | Featured Articles
Less than ten years ago, the U.S. was the epicenter of the pharmaceutical universe, with global firms establishing R&D centers throughout the U.S. to be near where the action was and build on the massive funding at the National Institutes of Health. But a funny thing happened over the past decade.
12/22/2009 | Featured Articles
Over the past two years, the traditional leaders of R&D—the U.S., Europe, and Japan—have struggled to maintain the basic essentials of their economies and have seen their overall R&D programs slide in relation those of emerging economies. The big emerging nations—China, India, and Brazil—were not immune to the global recession.
12/22/2009 | Featured Articles
The past several decades have heralded a revolution in the fundamental understanding of disease and disease progression. In particular, researchers have come to recognize the interconnectivity that exists between cellular tissue and organ systems in mammals, and that one system can no longer be studied in isolation.